factual

Rosiglitazone Caused ~70,000 Heart Attacks

Rosiglitazone, a Type 2 diabetes drug, was on the market for years (and as of last check still available in the US) when a 2007 meta-analysis suggested it had caused something like 70,000 heart attacks; of roughly 45 trials testing it, only about 15 had been published.

factualpending

Speaker

Jacob Stegenga

Evidence Quote

“in 2007, meta-analysis was done which suggested that in the handful of years that the drug had been on the market, it had caused something like 70,000 heart attacks.”

Source

Jacob Stegenga on Medical Nihilism— EconTalk
Created: 6/13/2026, 12:09:58 AM

Your notes

Loading notes...